Literature DB >> 17334383

A survey on patient perception of reduced-intensity transplantation in adults with sickle cell disease.

S Chakrabarti1, D Bareford.   

Abstract

The development of reduced-intensity conditioning (RIC) and the success of BMT for paediatric sickle cell disease (SCD) have raised the possibility of revisiting this prospect in adults as well. In a chronic debilitating disorder managed with supportive therapy, the patients' perception is critical in the advancement of any potential curative therapy. To explore this aspect, we undertook a questionnaire-based survey on 30 adults with SCD. Sixty two per cent of the patients were ready to accept a transplant-related mortality (TRM) >10%; 30% of them a TRM >30%. A risk of graft failure (GF) >10% was acceptable to 64%, with a risk >30% acceptable to 41%. Infertility was acceptable to only 50%. Chronic graft-versus-host disease (GVHD) was unacceptable to the majority (80%). Seventy six per cent% of patients had a full sibling and 60% were willing to participate in a clinical trial of RIC transplantation. This survey suggests that the majority of adults with SCD might be willing to consider a curative option such as RIC transplantation even with a high TRM or GF. The major concerns relate to chronic GVHD and infertility. There is an urgent need to explore RIC transplants in SCD patients within the framework of a clinical trial, considering patient perception regarding cure and complications.

Entities:  

Mesh:

Year:  2007        PMID: 17334383     DOI: 10.1038/sj.bmt.1705622

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  18 in total

Review 1.  HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide.

Authors:  E J Fuchs
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

2.  Nonmalignant diseases and treatments associated with primary ovarian failure: an expanded role for fertility preservation.

Authors:  Jennifer Hirshfeld-Cytron; Clarisa Gracia; Teresa K Woodruff
Journal:  J Womens Health (Larchmt)       Date:  2011-08-09       Impact factor: 2.681

3.  Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.

Authors:  Emanuele Angelucci; Susanne Matthes-Martin; Donatella Baronciani; Françoise Bernaudin; Sonia Bonanomi; Maria Domenica Cappellini; Jean-Hugues Dalle; Paolo Di Bartolomeo; Cristina Díaz de Heredia; Roswitha Dickerhoff; Claudio Giardini; Eliane Gluckman; Ayad Achmed Hussein; Naynesh Kamani; Milen Minkov; Franco Locatelli; Vanderson Rocha; Petr Sedlacek; Frans Smiers; Isabelle Thuret; Isaac Yaniv; Marina Cavazzana; Christina Peters
Journal:  Haematologica       Date:  2014-05       Impact factor: 9.941

4.  Traffic Light: prognosis-based eligibility for clinical trials of hematopoietic SCT in adults with sickle cell anemia.

Authors:  S J Rotz; M A O'Riordan; C Kim; M de Lima; M T Gladwin; J A Little
Journal:  Bone Marrow Transplant       Date:  2015-03-16       Impact factor: 5.483

5.  Diminished ovarian reserve in young women with sickle cell anemia.

Authors:  Lydia H Pecker; Sarah Hussain; Jaanvi Mahesh; Ravi Varadhan; Mindy S Christianson; Sophie Lanzkron
Journal:  Blood       Date:  2022-02-17       Impact factor: 22.113

6.  Barriers to hematopoietic cell transplantation clinical trial participation of african american and black youth with sickle cell disease and their parents.

Authors:  Nancy A Omondi; Stacy E Stickney Ferguson; Navneet S Majhail; Ellen M Denzen; George R Buchanan; Ann E Haight; Richard J Labotka; J Douglas Rizzo; Elizabeth A Murphy
Journal:  J Pediatr Hematol Oncol       Date:  2013-05       Impact factor: 1.289

Review 7.  Blood and marrow transplantation for sickle cell disease: overcoming barriers to success.

Authors:  Javier Bolaños-Meade; Robert A Brodsky
Journal:  Curr Opin Oncol       Date:  2009-03       Impact factor: 3.645

Review 8.  Blood and marrow transplantation for sickle cell disease: is less more?

Authors:  Javier Bolaños-Meade; Robert A Brodsky
Journal:  Blood Rev       Date:  2014-08-27       Impact factor: 8.250

Review 9.  Transplantation tolerance: from theory to clinic.

Authors:  Ephraim J Fuchs
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

10.  Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions.

Authors:  Shalini Shenoy
Journal:  Ther Adv Hematol       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.